Filters

60 Results

relevance


Excedrin Migraine Pain Relief

Ad Alert

Excedrin Migraine Pain Relief

A reader submitted a tip concerning the pricing of Excedrin Migraine Pain Reliever versus Excedrin Extra Strength Pain Reliever.

LASIK Providers Unclear on Risks

Ad Alert

LASIK Providers Unclear on Risks

The FDA sent warning letters to four LASIK providers for promoting the procedure on their websites without adequate warning about the risks involved.

Fungus Eliminator

Ad Alert

Fungus Eliminator

Forty-five million Americans are ‘fighting a losing battle’ against toenail fungus. Could this supplement be the solution?

CalmOptics

Ad Alert

CalmOptics

Don’t let the claims about these blue-light blocking glasses blind you to the facts.

Lullaby Hammock

Ad Alert

Lullaby Hammock

Marketer of baby hammock claims its product reduces the risk of SIDS but lacks the evidence to prove it.

Thursday Boot Co.

Ad Alert

Thursday Boot Co.

Company claims its boots are “Handcrafted in the USA” but not all of them are.

Hairburst

Ad Alert

Hairburst

Influencer’s lack of disclosure in Instagram post for hair vitamin may only be part of the problem.

Supple

Ad Alert

Supple

FTC slaps former couple that sold supplement drink for misleading consumers.

GlucoCoR

Ad Alert

GlucoCoR

FDA warns supplement maker about unapproved diabetes treatment claims.

Show More